 |
|
|
| |
Second-generation hepatitis B virus core inhibitors ABI-H2158 and ABI-H3733
have enhanced potency and target coverage for both antiviral inhibition and covalently closed circular DNA establishment activities
|
| |
| |
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
Dawei Cai, Marc Evanchik, Ran Yan, Renuka Kumar, Yuhua Zong, Qi Huang, Richard Colonno, Kathryn Kitrinos, Luisa M Stamm, William Delaney
Assembly Biosciences, Inc., South San Francisco, CA, USA
|
| |
|
|
|
|
|
